While military and trauma applications established the clinical foundation for chitosan hemostatic powders, surgical integration represents a high-growth segment that leverages the same rapid hemostatic mechanisms for elective and emergent operative procedures across multiple specialties. Cardiac and thoracic surgery captured 12.4% of surgical market share in 2025, as chitosan powders address...